These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7321293)

  • 1. Immune response of man to Habu-venom toxoid.
    Murata R; Fukushima H
    Jpn J Med Sci Biol; 1981 Aug; 34(4):197-212. PubMed ID: 7321293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of purified Habu snake-venom toxoid in guinea pigs and monkeys with special reference to HR1 component.
    Sadahiro S; Omori-Satoh T; Yamauchi K; Kondo S; Ishida S; Murata R
    Jpn J Med Sci Biol; 1981 Aug; 34(4):213-30. PubMed ID: 6798252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of adjuvants on the immunogenicity of Habu-venom toxoid in the monkey and the guinea pig.
    Sadahiro S; Kondo S; Yamamoto A
    Jpn J Med Sci Biol; 1981 Jun; 34(3):169-73. PubMed ID: 6796732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pH and lysine during detoxification of a hemorrhagic principle of Habu snake (Trimeresurus flavoviridis) venom with formalin on the immunogenicity of the toxoid.
    Sadahiro S; Omori-Satoh T; Kondo S; Matuhasi T
    Jpn J Med Sci Biol; 1984; 37(5-6):225-31. PubMed ID: 6443133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the adequate composition of diphtheria and tetanus toxoids-with reference to the amounts of toxoids and aluminum adjuvant.
    Someya S; Mizuhara H; Murata R; Kurokawa M
    Jpn J Med Sci Biol; 1981 Feb; 34(1):21-35. PubMed ID: 7265558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of Habu toxoid--from the view point of public health center].
    Uda H; Tomari T; Yanagihashi T; Nozaki M; Kodama K
    Nihon Koshu Eisei Zasshi; 1993 Jun; 40(6):482-90. PubMed ID: 8347864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization against neonatal tetanus in New Guinea.
    Hardegree MC; Barile MF; Pittman M; Schofield FD; Maclennan R; Kelly A
    Bull World Health Organ; 1970; 43(3):439-51. PubMed ID: 5312998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
    Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
    Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the improvement of treatment of Habu (Trimeresurus flavoviridis) bites. 9. Studies on the immunogenicity of the purified Habu venom toxoid by alcohol precipitation.
    Sawai Y; Chinzei H; Kawamura Y; Okonogi T
    Taiwan Yi Xue Hui Za Zhi; 1972 Jun; 71(6):421-30. PubMed ID: 4573916
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxoid preparation from venom of Bothrops colombiensis (Central and South American snake).
    Rodriquez-Acosta A; Alonso R; Castro I; Aguilar A; Giron ME
    Roum Arch Microbiol Immunol; 1991; 50(3):209-14. PubMed ID: 1821162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II safety and immunogenicity study of type F botulinum toxoid in adult volunteers.
    Edelman R; Wasserman SS; Bodison SA; Perry JG; O'Donnoghue M; DeTolla LJ
    Vaccine; 2003 Oct; 21(27-30):4335-47. PubMed ID: 14505916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and standardization of formol toxoid from the venom of Trimeresurus flavoviridis (Habu).
    Kondo H; Murata R
    Taiwan Yi Xue Hui Za Zhi; 1972 Jun; 71(6):413-9. PubMed ID: 4633952
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenicity of a toxoid of Habu (Trimeresurus flavoviridis) venom in various animal species including man.
    Kondo H; Sadahiro S; Kondo S; Yamauchi K; Murata R
    Jpn J Med Sci Biol; 1971 Dec; 24(6):365-77. PubMed ID: 5003950
    [No Abstract]   [Full Text] [Related]  

  • 14. Active immunization of man with toxoid of habu (Trimeresurus flavoviridis) venom.
    Someya S; Murata R; Sawai Y; Kondo H; Ishii A
    Jpn J Med Sci Biol; 1972 Feb; 25(1):47-51. PubMed ID: 4537701
    [No Abstract]   [Full Text] [Related]  

  • 15. Active immunization of cattle with a bothropic toxoid does not abrogate envenomation by Bothrops asper venom, but increases the likelihood of survival.
    Herrera M; González K; Rodríguez C; Gómez A; Segura Á; Vargas M; Villalta M; Estrada R; León G
    Biologicals; 2017 Mar; 46():1-5. PubMed ID: 28122669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The standardization of Cl. perfringens antigens and antisera.
    Jansen BC
    Dev Biol Stand; 1976; 32():35-44. PubMed ID: 187510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adequate immune response to tetanus toxoid and failure of vitamin A and E supplementation to enhance antibody response in healthy children.
    Kutukculer N; Akil T; Egemen A; Kurugöl Z; Akşit S; Ozmen D; Turgan N; Bayindir O; Cağlayan S
    Vaccine; 2000 Jul; 18(26):2979-84. PubMed ID: 10825599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally.
    Levine MM; Hughes TP; Young CR; O'Donnell S; Craig JP; Holley HP; Bergquist EJ
    Infect Immun; 1978 Jul; 21(1):158-62. PubMed ID: 101456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined vaccination with BCG and toxoid antigens.
    Guld J; Ladefoged A; Ramhøj W
    Bull World Health Organ; 1978; 56(6):957-64. PubMed ID: 310736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid.
    Pittman PR; Hack D; Mangiafico J; Gibbs P; McKee KT; Friedlander AM; Sjogren MH
    Vaccine; 2002 May; 20(16):2107-15. PubMed ID: 11972980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.